ADVANCED/METASTATIC BREAST CANCER
Clinical trials for ADVANCED/METASTATIC BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED/METASTATIC BREAST CANCER trials appear
Sign up with your email to follow new studies for ADVANCED/METASTATIC BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise in early breast cancer trial
Disease control CompletedThis early-phase trial tested a new experimental drug called AZD2014 combined with the standard hormone therapy fulvestrant in 99 people with advanced ER+ breast cancer. The main goals were to check the safety of the combination and find the right dose. Researchers also looked fo…
Matched conditions: ADVANCED/METASTATIC BREAST CANCER
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Breast cancer drug IBRANCE® under Real-World watch in korea
Knowledge-focused CompletedThis completed study looked at how safe and effective the drug IBRANCE® is for women with advanced breast cancer when used in everyday medical practice. Researchers tracked 552 women in Korea for side effects and how well the drug worked. The goal was to gather real-world informa…
Matched conditions: ADVANCED/METASTATIC BREAST CANCER
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC